K. A. Malle Pharmaceuticals Limited

Pharmaceutical company specializing in manufacturing API's, drug intermediates, and specialty chemicals.

1982 | Mumbai, Maharashtra (India) | Active
Last Updated:

K. A. Malle Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 1.29 Cr
  • Company Age 42 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 47.65 Cr
  • Satisfied Charges ₹ 10.73 Cr
  • Revenue Growth -14.13%
  • Profit Growth -406.16%
  • Ebitda -293.52%
  • Net Worth -180.34%
  • Total Assets -9.33%

About K. A. Malle Pharmaceuticals

K. A. Malle Pharmaceuticals Limited (KAMPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 May 1982 and has a history of 42 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as K. A. Malle Leasing Company Limited. The Company is engaged in the Chemicals And Materials Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.29 Cr.

The company currently has active open charges totaling ₹47.65 Cr. The company has closed loans amounting to ₹10.73 Cr, as per Ministry of Corporate Affairs (MCA) records.

Rahul Bhomavat, Divyakumar Jain, Shanu Podar, and One other member serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U70101MH1982PLC027110

  • Company No.

    027110

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    11 May 1982

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Chemicals and Materials
Pharma

What products or services does K. A. Malle Pharmaceuticals Limited offer?

K. A. Malle Pharmaceuticals Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Content Writing Service, Research Development Services.

Company report

K. A. Malle Pharmaceuticals Limited

Explore comprehensive data for K. A. Malle Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at K. A. Malle Pharmaceuticals?

Board Members (4)

NameDesignationAppointment DateStatus
Rahul Bhomavat Country flag representing In Director 08-Jun-2018Current
Divyakumar Jain Country flag representing In Director 08-Aug-2018Current
Shanu Podar Country flag representing In Director 18-Feb-2008Current
Hemant Chaturvedi Country flag representing In Director 08-Nov-2021Current

Financial Performance of K. A. Malle Pharmaceuticals.

K. A. Malle Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.13% decrease. The company also saw a substantial fall in profitability, with a 406.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 180.34%.

K. A. Malle Pharmaceuticals revenue growth over time
K. A. Malle Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-14.13%
Revenue from Operations
-16.73%
Total Assets
-9.33%
Profit or Loss
-406.16%
Net Worth
-180.34%
EBITDA
-293.52%

What is the Ownership and Shareholding Structure of K. A. Malle Pharmaceuticals?

In 2023, K. A. Malle Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹47.65 Cr

Satisfied Charges

₹10.73 Cr

Charges Breakdown by Lending Institutions

  • The Cosmos Co-Operative Bank Ltd : 46.65 Cr
  • Standard Chartered Bank : 1.00 Cr

Latest Charge Details

DateLenderAmountStatus
30 Jun 2008The Cosmos Co-Operative Bank Ltd₹46.65 CrOpen
06 Dec 1985Standard Chartered Bank₹1.00 CrOpen
09 Apr 2013The Cosmos Co-Operative Bank Ltd.₹5.00 MSatisfied
21 Apr 2012The Cosmos Co-Op Bank Ltd₹0.70 MSatisfied
23 Jul 2011The Cosmos Co-Op Bank Ltd₹7.50 MSatisfied

How Many Employees Work at K. A. Malle Pharmaceuticals?

K. A. Malle Pharmaceuticals has a workforce of 119 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for K. A. Malle Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of K. A. Malle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K. A. Malle Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on K. A. Malle Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    K. A. Malle Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    K. A. Malle Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Hemant Kumar Chaturvedi was appointed as a Director was appointed as a Director on 08 Nov 2021 & has been associated with this company since 3 years 5 months .

  • Charges

    A charge registered on 21 Apr 2012 via Charge ID 10353329 with The Cosmos Co-Op Bank Ltd was fully satisfied on 05 Jul 2019.

  • Director Appointment

    Divyakumar Jain was appointed as a Director was appointed as a Director on 08 Aug 2018 & has been associated with this company since 6 years 8 months .

  • Director Appointment

    Rahul Radheshyam Bhomavat was appointed as a Director was appointed as a Director on 08 Jun 2018 & has been associated with this company since 6 years 10 months .

Frequently asked questions

  • What is the Incorporation or founding date of K. A. Malle Pharmaceuticals Limited?

    K. A. Malle Pharmaceuticals Limited was incorporated on 11 May 1982.

  • What is authorized share capital and paid-up capital of K. A. Malle Pharmaceuticals Limited?

    The authorized share capital of K. A. Malle Pharmaceuticals Limited is ₹ 5.00 Cr and paid-up capital is ₹ 1.29 Cr.

  • Who are the current board members & directors of K. A. Malle Pharmaceuticals Limited?

    Currently 4 directors are associated with K. A. Malle Pharmaceuticals Limited.

    • Rahul Radheshyam Bhomavat
    • Divyakumar Jain
    • Shanu Pramod Podar
    • Hemant Kumar Chaturvedi

  • What is the registered address of K. A. Malle Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of K. A. Malle Pharmaceuticals Limited is 2 Krishna Dham L.S. Raheja Marg Township Malad East, India, Mumbai, Maharashtra, 400097.

  • What is the corporate identification number (CIN) and company number of K. A. Malle Pharmaceuticals Limited?

    The corporate identification number (CIN) of K. A. Malle Pharmaceuticals Limited is U70101MH1982PLC027110 and the company number is 027110 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of K. A. Malle Pharmaceuticals Limited?

    The Official website of K. A. Malle Pharmaceuticals Limited is https://www.kamalle.com

  • What has been the recent revenue trend for K. A. Malle Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for K. A. Malle Pharmaceuticals Limited has fallen by -14.13%.

  • How many employees does K. A. Malle Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 119 employees are currently employed by K. A. Malle Pharmaceuticals Limited.

  • What change has been observed in the net worth of K. A. Malle Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of K. A. Malle Pharmaceuticals Limited has experienced an downturn of -180.34%.

  • What are the total open charges for K. A. Malle Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for K. A. Malle Pharmaceuticals Limited amount to ₹ 47.65 Cr.

  • When was the last Balance Sheet of K. A. Malle Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for K. A. Malle Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers